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The decision which prospective parents face concerning mid-trimester amniocentesis for prenatal diagnosis
was examined by decision analysis. The prospective parents' decision depends on the likelihood ofthe birth of
a child affected by a genetic disorder, the risk of amniocentesis, and the probability that the diagnoses
provided by the amniocentesis will be correct. The couple's decision must also depend on their attitudes
toward each possible outcome. The likelihoods of the outcomes can be obtained from appropriate medical
consultation, while the relative costs or burdens of the outcomes should be obtained from the prospective
parents. A truly informed decision for this couple can then be formulated from these probabilities and values,
thus allowing genetic counseling to be more directive. The technique is illustrated for the prenatal diagnosis of
Down's syndrome, meningomyelocele, and Duchenne muscular dystrophy.
Amniocentesis has become increasingly available as a tool for prenatal diagnosis of
a variety ofgenetic disorders [1-3], and several authors have suggested that prenatal
diagnosis be made available to large segments ofthe population [4,5]. Unfortunately,
the decision to employ amniocentesis is difficult [6]: prenatal diagnosis raises ethical
issues which certainly do not rest solely with the physician for their resolution.
The medical issues relating to amniocentesis are not simple: the procedure can be
followed by complications [1,2,4,7,8], most commonly spontaneous abortion, and
can provide erroneous information [7-13]. Since amniocentesis and therapeutic
abortion often bewilder prospective parents, the physician cannot assume that merely
describing the procedure (and even its associated false positive and false negative
rates) provides a couple with a basis for making a truly informed decision.
This problem can be approached by decision analysis, a general technique for
making choices under the conditions ofuncertainty [14-18]. Such analyses are being
applied to an increasing number of problems in medicine [19-24]. The technique
replaces a complex decision with a series of simpler decisions. In so doing, it
separates the probabilities of the various outcomes from the relative values of these
outcomes; therefore, it has been proposed as a means of obtaining more patient
participation in the clinical decision-making process [22,25]. Prior medical applica-
tions of decision analysis have dealt with situations in which the optimal choice was
determined largely by the medical issues. In contrast, decisions about prenatal
diagnosis are highly dependent upon the parents' attitudes toward the various out-
comes.
275
'This research was supported in part by the Health Resources Administration, U.S. Public Health Service, undergrant
I ROI MB 00107-01 from the Bureau of Health Manpower, grant HS 0091 1-01 from the National Center for Health
Services Research, and Training Grant Genetics 5 TOI GM 02249-02.
Please address reprint requests to: Dr. Stephen Pauker, New England Medical Center Hospital, 171 Harrison Ave.,
Boston, MA 02111
Copyright ° 1977 by The Yale Journal of Biology and Medicine, Inc.
All rights of reproduction in any form reserved.PAUKER AND PAUKER
THE PROBLEM STATED
Consider a set of prospective parents concerned about the possibility of giving
birth to a child affected by a disease detectable by amniocentesis. Assume that they
would have a therapeutic abortion if the fetus were known to be affected. If they
would not consider a therapeutic abortion, then the procedure would have been
performed largely for purposes of reassurance; although amniocentesis in that
circumstance may be appropriate, it is not included in this analysis.
The Decision Tree
This decision can be represented by the tree shown in Fig. 1. The square node on
the left denotes the choice between having an amniocentesis and carrying a pregnancy
to term with no further information about the fetus. Each circular node denotes a
chance event which neither the physician nor the parents can control.
The first tier of chance nodes denotes the possibility of spontaneous abortion
subsequent to the first trimester. The probability of a spontaneous abortion without
amniocentesis is denoted by s; the probability after amniocentesis is s + a. The second
tier of chance nodes describes the actual state of the fetus. The probability of an
affected fetus is d; the probability ofan unaffected fetus is therefore 1- d. This actual
diagnosis, however, is unknown during the pregnancy. The final tier ofchance nodes
denotes the result of the amniocentesis. The chance of an abnormal amniocentesis
although the fetus is actually unaffected (a false positive result) isp. Thus, the chance
of a normal result given an unaffected fetus is 1 - p. The chance of a normal
amniiocentesis although the fetus is affected (a false negative result) is n; thus the
chance of detecting an affected fetus is 1 - n.
Utility of the Outcomes. The possible outcomes are each assigned a value, or
utility, which represents their relative desirability to the prospective parents. The first
and fourth branches of the tree represent the occurrence of a spontaneous abortion
after the first trimester; the utility of that outcome is denoted by Us. The second and
fifth branches represent the birth of an unaffected child; the utility ofthat outcome is
Uu. The third and eighth branches represent the birth of an affected child; the utility
of that outcome is UA. Finally, the sixth and seventh branches represent an abnormal
result of the amniocentesis followed by a therapeutic abortion. In the sixth branch
the result was falsely positive-an unaffected fetus was aborted. The utility of that
outcome is UTU. In the seventh branch, the amniocentesis result was correct-an
affected fetus was aborted. The utility of that outcome is UTA. These definitions are
summarized in Table 1.
In specifying any set of utilities, the absolute values used can be arbitrary; the only
requirement is that the utilities be represented on a single consistent scale. For most
parents the birth ofan unaffected child would be the best outcome and the birth ofan
affected child would be the worst outcome; the occurrence ofa spontaneous abortion
and the performance of a therapeutic abortion would have intermediate utility.
Probability ofthe Outcomes. The likelihood of any of the eight possible outcomes
is equal to the product of the probabilities along the path leading to that outcome.
For example, the probability of an unaffected child after amniocentesis (branch 5) is
(1 - [s + a]) x (1 - d) x (1 - p). The probability of each of the eight outcomes is
summarized in Table 1.
Assumptions of the Analysis
Several assumptions were made in structuring this problem. Any decision about
amniocentesis must involve similar assumptions, although they are often implicit and
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DECISION SPONTANEOUS ACTUAL RESULT OF
ABORTION DIAGNOSIS TEST
NO AMNIOCENTESIS
SPONTANEOUS ABORTION
s
UNAFFECTED CHILD
(l-d)
(l-s)
CONTINUED
PREGNANCY
d
AFFECTED CHILD
SPONTANEOUS ABORTION
(sua)
C1-(staJ )
CONTINUED
PREGNANCY
TRUE NEGATIVE TEST-
UNAFFECTED CHILD
UNAFFECTED C1-p)
FETUS
(1-d) p
FALSE POSITIVE TEST-
THERAPEUTIC ABORTION
d
AFFECTED
FETUS
TRUE POSITIVE TEST-
THERAPEUTIC ABORTION
(1-n)
n
FALSE NEGATIVE TEST-
AFFECTED CHILD
FIG. 1. The Decision Tree. The square node at the left denotes the decision; each circular node denotes a chance event
not under the control ofeither the physician or the parents. The symbol on the interior ofeach branch ofthe chance nodes
denotes the probability of that event occurring, given that all prior events on that path have already occurred.
TABLE I
Utility and Probability of Each Outcome*
Outcome Utility Probability
No Amniocentesis
Spontaneous abortion Us s
Unaffected child Uu (1 - s)(I - d)
Affected child UA (-s)
Amniocentesis
Spontaneous abortion Us (s + a)
Unaffected child Uu (I - [s + a])(I- d)(l -p)
Therapeutic abortion of unaffected fetus UTU (1 - [s + a]XI - d)p
(false positive test)
Therapeutic abortion of affected fetus UTA (- [s + a])d(l - n)
(true positive test)
Affected child UA (1 - [s + a])dn
*d = probability of fetus being affected by given disease
s = spontaneous abortion rate without amniocentesis
a = additional chance of spontaneous abortion after amniocentesis
n = false negative rate
p = false positive rate
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not available for examination and discussion. The technique of decision analysis
requires these assumptions to be explicit.
This analysis does not consider the issues ofadoption and subsequent pregnancies;
it assumes that the effect of these factors can be incorporated into the utilities
assigned to the five outcomes. The only "cost" of amniocentesis considered here is
spontaneous abortion; maternal complications, pain, non-fatal fetal complications,
and dollar cost are ignored. This analysis considers only a single test for an affected
fetus; if several separate tests are to be done, then the probability of an affected fetus,
the utility of an affected child, and the false positive and negative rates must be
adjusted appropriately.
Occasionally, an amniocentesis will not be successful; either no fluid will be
obtained or the fetal fibroblasts centrifuged from the amniotic fluid will fail to grow
in cell culture. Although this occurs in approximately ten percent of amniocenteses, if
a second sample2 is obtained this "no data" rate falls to under one percent. Although
a portion ofthese residual "no data provided" amniocenteses will result in an affected
child and should be included among the false negatives, this effect is small and can be
ignored.
ANALYSIS OF THE TREE
When the decision about prenatal diagnosis is made, the parents cannot know
whether the fetus is affected; they must make their decision despite this uncertainty.
Decision theory [14-24] states that they should choose the option which has the
higher expected value, calculated by summing the product of the probability and the
utility of each of the possible outcomes of that option. For example, the expected
value of "No Amniocentesis," EVNoAmnio, is (referring to Table 1):
sUs +[(I -s)(l -d)]Uu + [(1 -s)d]UA.
In a similar manner, one can calculate the expected value of"Amniocentesis," EVAmnio.
The parents would be expected to be indifferent toward amniocentesis if the
expected values of the two options were equal. Thus, the probability (d) of a child's
being affected at which EVAmJio equals EVNoAmnio is a threshold probability [23]: for
probabilities above the threshold, amniocentesis should be performed; for probabili-
ties below the threshold, amniocentesis should not be performed. One can determine
the threshold by setting EVAm.nio = EVNoAmnio and solving for d. The resulting expres-
sion for the threshold can be simplified by several substitutions.
Definition of the Costs of the Outcomes. As used in this paper, a "cost" is a
measure of the relative burden [27] of an outcome to the prospective parents. The
differences between the utility of an unaffected child (Uu) and the utility of each of
the four other outcomes is a measure of the relative burden of those latter outcomes.
Fig. 2 summarizes these costs. The cost of an affected child (CA)is the difference be-
tween the utility of an unaffected child and the utility of an affected child. The cost of
a spontaneous abortion (Cs) is the difference between the utility of an unaffected
child and the utility of a spontaneous abortion. Similarly, the cost of the therapeutic
abortion of an affected fetus (CTA) is the difference between the utility of an unaf-
fected child and the utility of such an abortion; the cost ofthe therapeutic abortion of
an unaffected fetus (CTU) is the difference between the utility of an unaffected child
and the utility of such an abortion.
2Although the risk of spontaneous abortion might be expected to increase with repeated amniocenteses, this does not
occur until the number of attempts exceeds three [26].
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UTILITY
UA UTU UTA US UU
-CS- SPONTANEOUS ABORTION
| CTA- THERAPEUTIC ABORTION OFAFFECTED FETUS
I - C - ITU THERAPEUTIC ABORTION
OF UNAFFECTED FETUS
CA' I AFFECTED CHILD
FIG. 2. The Relations Among Utilities and Costs. The horizontal axis represents the scale ofutility, or relative value, of
each of the five outcomes: unaffected child (Uu), spontaneous abortion (Us), therapeutic abortion of an affected fetus
(UTA), therapeutic abortion of an unaffected fetus (UTU) and an affected child (UA). Each labelled interval is the difference
in utility between one of the latter four outcomes and the best outcome, the birth of an unaffected child. Thus, each
interval is the relative cost of an outcome.
Definition ofthe Risk ofAmniocentesis. The ratio, a!( 1- s), of the "additional
chance ofspontaneous abortion afteramniocentesis" to the "probability ofcontinued
pregnancy" is a measure of the risk of amniocentesis and will be denoted by r. This
risk must, by definition, fall between zero and one. In this paper we assume that s is
5% and a is 0.5%; thus, r is 0.005. One recent study [4,26] demonstrated that the risk
might be even lower, i.e., s was 3.2%, a was 0.3%, and thus r was 0.003.
The Threshold Probability
We shall denote the threshold probability by T. Making the above substitutions,
we find that
(1-r)pCTU + rCs Tr
(1-r)[pCrU-(I-n)CTA-nCA] + CA
In this equation, r is the risk of the amniocentesis, n is the false negative rate,p is the
falsepositive rate, Csis the cost ofspontaneous abortion, CA is the cost ofanaffected
child, CTA is the cost of the therapeutic abortion of an affected fetus and CTU is the
cost ofthe therapeutic abortion ofan unaffectedfetus. The errorand risk rates (n,p,
and r) are measured on a scale of zero to one. The costs may be measured on any
consistent scale, but a scale of zero to 100 is most convenient, with the highest cost
(usually CA, the cost of an affected child), being defined as 100. Although the
equation appears complex, the advent of small, hand-held calculators makes its use
feasible.
The most important factors governing the decision about amniocentesis are the
relative cost or burden oftherapeutic abortion3 (CTA) and the probability ofachild's
being affected (d). The equation for the threshold probability can be used to create a
graphical representation ofthis relation, as shown in Fig. 3. If, for a particular set of
31n our experience with this technique, most parents consider CTAand CTU to be ofsimilar magnitude; in such cases we
use CTA to represent both costs.
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COST (BURDEN)
ABORTION (CTA)
0.2 0.4 0.6 0.8 1.0
PROBABILITY OF
A CHILD'S BEING AFFECTED (d)
FIG. 3. The Relation Between the Probability of a Child's Being Affected and the Cost ofTherapeutic Abortion. The
curve establishes two areas of recommendation, "Amniocentesis" and "No Amniocentesis." If a point corresponding to
the CTAand d(e.g., 25 and 0.5) for a given couple is plotted in the figure, then the area within which that point lies specifies
the optimal choice for that couple. For this illustrative curve, we assumed that Cs, CTAand CTU were allequal, thatp was
0.43, and that n was 0.005 (see Case 3). In order to make the diagram clearer, wearbitrarily assigned r a value of0.1. Since
the actual risk of amniocentesis is much lower (0.005), the true curve would be shifted far to the left and the shaded area
would be much larger.
parents, a point corresponding both to the cost or burden that therapeutic abortion
would be for those parents and to the probability ofa child's being affected is plotted
on that graph, e.g., CTA of 25 and d of 0.5, then the position of that point will
correspond to the optimal choice for those parents. Ifthe point lies in the shaded area
below the curve, then amniocentesis would be appropriate.
INTERPRETATION OF THE SOLUTION
The threshold probability is affected by the relative burden of the outcomes, the
risk of amniocentesis, and the quality of information provided by the test, i.e., the
false positive and false negative rates. Table 2 summarizes the effects of changes in
various parameters upon the threshold, while Fig. 4 illustrates the effects ofvariation
in the risk and information content of amniocentesis for a broad range of values
which should encompass most situations likely to be encountered clinically. In that
figure, each curve is analogous to the curve in Fig. 3. The area beneath each curve
specifies those situations in which-amniocentesis should be recommended.
The Risk of Amniocentesis. The left-hand portion of Fig. 4 shows the effect of
changes in the risk ofamniocentesis (r). Each curve describes the relation between the
cost of abortion and the probability of an affected fetus for a single value of r. For
prospective parents to continue to elect amniocentesis as the risk of the procedure
increases, either their perception of the burden oftherapeutic abortion must decrease
or the probability of their having an affected child must increase.
The Quality ofInformation. The right-hand portion of Fig. 4 illustrates the effect
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TABLE 2
Effects on the Threshold
Increase in Parameter Interpretation Effect on Threshold
CA Increased burden of Decrease
an affected child
Cs Increased burden of Increase
spontaneous abortion
CTA Increased burden of Increase
therapeutic abortion
of an affected fetus
CTU Increased burden of Increase
therapeutic abortion
of an unaffected fetus
a,s,r* Increased risk Increase
of amniocentesis
n Increased chance Increase
of false negative
p Increased chance Increase
of false positive
*Increases in either a or s will increase r.
100 .00/
.0/
80 /0
COST (BURDEN) 6.3
OF THERAPEUTIC 60
ABORTION (CTA) EFFECT OF
40 THE RISK OF
AMNIOCENTESIS
2
0 I
0 0.2 0.4 0.6 0.8 1.0 0 0.2 0.4 0.6 0.8 1.0
PROBABILITY OF A CHILD'S BEING AFFECTED (d)
FIG. 4. The Effects of Risk and Errors on the Thresholds. Each diagramcontains a set of curves analagous to the curve
in Fig. 3. The left-hand diagram illustrates the effect ofchanges in the risk ofamniocentesis. Risks (r) of .001, .01, .10 and
.30 are plotted for false positive (p) and false negative (n) rates of zero. The right-hand diagram illustrates the effects of
errors. False positive and false negative rates of0.0, .05, .10 and .20 are plotted, for a risk of .005. It was assumed that Cs,
CTA and CTU were all equal.
of the information content of the amniocentesis on the threshold. As the error rates
increase, the threshold increases. Thus, as the information provided becomes less
reliable, parents should be less likely to choose amniocentesis.
The Effect of Changes in the Model
The decisions suggested by this analysis will be optimal only to the extent that our
model of the outcomes of pregnancy is correct. We shall now modify the original
model and consider the effect on the decision of two additional outcomes-a child
damaged by the amniocentesis and a child affected by anotherdisorder, not subject to
prenatal detection.
The effect of non-fatal fetal complications of amniocentesis would be to increase
the threshold probability. Specifically, both the numerator and the denominator of
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the threshold equation should be increased by (I
- r)(l
- P)Pdam Cdam, where Pdam is
the probability of such complications and Cdam is the cost of that outcome. The birth
of a child presumably damaged by amniocentesis is, however, extremely rare and
should exert little effect on the decision.
The effect of additional causes of birth defects would be to decrease the threshold
probability. Specifically, (r(l -P) +P)P),her Cother should be subtracted from both the
numerator and the denominator of the threshold equation, where Pother is the chance
of a child's being affected by any such non-diagnosable disorder and Cothe, is the cost
or burden of such a disorder. Thus, the existence of non-diagnosable birth defects
should make parents more amenable to amniocentesis. Although such disorders are
not uncommon, i.e., approximately 2-4% of pregnancies may result in a major
congenital malformation, the calculated thresholds would be changed only to a
minor extent since both r and p are small.
Genetic Counseling
Although the literature suggests that genetic counseling should be non-directive
[1,2], that goal is rarely accomplished [28]. The physician imparts his own biases
either subtly or at the explicit request of the parents. Furthermore, even if such non-
directive counseling could be accomplished, the parents would still face the difficult
task of remembering all the relevant data provided and incorporating them into a
rational decision. Since the optimal decision for a particular couple can be deter-
mined from the equation for the threshold probability, it might be more reasonable
to direct the counseling toward that "best" decision.
It is, of course, not necessary for the parents to understand, or even to be aware of,
the mathematical details of this analysis. Rather, they should be counseled about the
consequences of pregnancy with and without amniocentesis. The genetic counselor
should be aware ofthe information content (n andp) and the risk (r) of the procedure
in the hands of his obstetrical and genetic colleagues. If he could obtain measures of
the parents' attitudes toward the various outcomes, then he could provide more
explicit guidance.
OBTAINING THE PARENTS' ATTITUDES
To use this analysis, the physician must have some means of assessing, in a
quantitative manner, the parents' attitudes both toward abortion and toward having
an affected child. The costs of abortion are determined largely by the parents'
perception of the "cost" of an affected child. If they view an affected child as a grave
calamity, the relative cost of abortion will be low; if they view an affected child as a
minimal inconvenience, then the relative cost of abortion will be high. The use of
illustrations like Fig. 1 can make such counseling easier, and the actual determination
of costs may help the parents understand the problem.
A convenient method is available for obtaining such costs in the course of the
counseling that precedes the decision about amniocentesis. The physician first pres-
ents the five possible outcomes and asks which would be the best and which would be
the worst for the prospective parents. Assume that the best and worst outcomes
chosen by the couple are "unaffected child" and "affected child," respectively. Assign
a cost of 100 to the worst outcome (CA = 100). What remains is to assign consistent
costs to the remaining three outcomes: spontaneous abortion (Cs), the therapeutic
abortion of an affected fetus (CTA ) and the therapeutic abortion of an unaffected
fetus (CTU )
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The burden oftherapeutic abortion is considered first. Explain to the parents that
they will be asked to make some difficult choices in several hypothetical situations.
Ask them to assume that the woman is pregnant and that they have a fifty-fifty
chance of having an affected child. If nofurther diagnostic information about that
pregnancy were available, would they elect to have a therapeutic abortion? If they
answer"yes," ask them whether they would still elect a therapeutic abortion if the
chance of an affected child were twenty-five percent, or ten percent. By answering a
series of such questions, the couple can specify that point at which they would be
indifferent between therapeutic abortion and carrying the pregnancy to term. This
point of indifference determines the cost of therapeutic abortion. Thus, prospective
parents who would be indifferent if their chance ofhaving an affected child were 25%
effectively assign a cost of 25 to therapeutic abortion.
The burden of spontaneous abortion is considered next. Although some parents
assign nearly equal costs to therapeutic and spontaneous abortion, many assign a
somewhat lower cost to spontaneous abortion. To obtain Cs, ask the parents to
consider a hypothetical pregnancy with no further diagnostic information available.
For various probabilities of having an affected child, ask them to express preference
between carrying the pregnancy to term and spontaneously aborting. Again the cost
of spontaneous abortion (Cs) is equal to the likelihood at which they would be
indifferent.
The burden ofthe therapeutic abortion of an unaffectedfetus must be determined
for those parents who do not consider all therapeutic abortions to be of equal cost.
For such parents CTA and CTU must be assessed separately. To assess the cost of the
therapeutic abortion of an affected fetus, ask the couple to consider the hypothetical
pregnancy described above (with no further diagnostic information available). Ask
them to specify, for various chances of having an affected child, a preference between
that pregnancy and the therapeutic abortion of a different hypothetical pregnancy in
which the aborted fetus isfound to be affected. The point of indifference determines
CTA. The parents can assessCTU in a similar manner, but now they must consider the
choice between the "no further information available" pregnancy and the therapeutic
abortion of a different pregnancy in which the fetus is found to be unaffected.
ILLUSTRATIVE CASES
This section will present three typical situations in which amniocentesis might be
employed and where the techniques presented above can help the prospective parents
make their decision.
Case 1: Down's Syndrome
A twenty-five year old woman seeks genetic counseling three years after the birth of
a child with Down's syndrome. She and her husband wish to have another child but
are frightened of the prospect of another affected child and reluctant to consider
therapeutic abortion. The mother is found to have a balanced D-G translocation;
thus, the chance of a recurrence is roughly 10% [29].
Analysis. Assume that karyotyping for detection of translocation trisomy 21 has
reported false positive and false negative rates of 0.5% in your laboratory [7-13,26].
The parents felt that the burden of therapeutic abortion of either an affected or an
unaffected fetus would be high. They were indifferent between therapeutic abortion
and carrying a pregnancy to term when their chance of having a child with Down's
syndrome reached 85% (CIA = 85 and CTU = 85); they were indifferent between
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carrying the pregnancy to term and spontaneous abortion when their chance of
having an affected child reached 60% (thus, Cs = 60).
Using the equation with r = 0.005, n = 0.005, p = 0.005, CA = 100, CS= 60, CTA = 85
and CTU = 85, one finds that ifthe probability of having an affected fetus is above 0.05
then amniocentesis is the better choice. Despite this couple's initial reluctance to
consider therapeutic abortion, they should be encouraged to have an amniocentesis
because their 10% recurrence risk is above the 5% threshold calculated from their
own values.
Case 2: Meningomyelocele
A couple seeks genetic counseling after the death of their first child with menin-
gomyelocele. Careful examination of that child revealed no evidence of a syndrome
or chromosomal abnormality [30]. They would like to have additional children but
would prefer therapeutic abortion to the prospect of having another affected child.
Analysis. This couple has a 2% recurrence risk for this multifactorial disorder [30].
Discussion with these parents reveals thatfor them Cs = 5, CTA = 20 and C TU = 60.
However, the laboratory in your area has reported a false positive rate of 1% for the
detection of neural tube defects by amniotic fluid alpha-fetoprotein concentration.
Since 10% of these defects are closed and therefore not detectable by this technique,
the false negative rate is roughly 10% [31-34]. Using the above values, one finds the
threshold probability to be 0.009, well below the recurrence risk. Thus, these parents
should be encouraged to have amniocentesis. Note, however, that if the false positive
rate of alpha-fetoprotein determination by your laboratory were 5%, the threshold
would then be 4%, somewhat higher than the 2% recurrence risk for this couple. In
that situation, the better choice would be to decline amniocentesis.
Case 3: Duchenne Muscular Dystrophy
A couple with a positive family history for Duchenne muscular dystrophy seeks
information about prenatal diagnosis. The woman's brother and maternal uncle died
of this disorder. Exercise CPK determinations were performed on the woman for
carrier detection [35], but the results were equivocal. The couple wish to consider the
possibility of prenatal sex determination with the prospect of aborting a male fetus.
Analysis. Since the woman's chance of being a carrier for this X-linked recessive
disorder is 50%, the chance of a male child's being affected is 25%. Since only
25% of males and no females will be affected, the chance of this couple's having
an affected child is 12.5%. All of the female fetuses (50%) and 75% of the male
fetuses (50% X 75%, or 37.5%) will be unaffected (total 87.5% of all fetuses),
but 37.5%/87.5%, or 43% of these will be males and therefore subject to thera-
peutic abortion. Thus, the false positive rate (p) for detection of affected fetuses by
prenatal sex determination is 0.43. The false negative rate (n) for detecting affected
fetuses will be determined by the error rate of prenatal sex determination,
roughly 0.005 [7-13,26].
These parents are concerned about the prospect of aborting an unaffected fetus.
Lengthy discussion reveals thatfor them CTU = 90, CTA = 20 and Cs =10. Using these
values, we find that the threshold probability is 0.33. The risk of a child's being
affected (0.125) is well below this threshold; hence this couple should be encouraged
to decline amniocentesis. The high threshold relates largely to the high false positive
rate in using prenatal sex determination to detect fetuses affected with muscular
dystrophy.
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DISCUSSION
The decision of whether or not to utilize prenatal diagnosis must rest with the
prospective parents who seek genetic counseling. Unfortunately the choice is not
simple [6]. It involves balancing the risk of amniocentesis against the information
which the procedure can provide. The medical literature does not deal with the
problem in a clear, logical fashion. Although amniocentesis may be indicated when
the chance ofcomplications from the procedure is less than the chance ofan affected
child [3], the decision must reflect the attitudes of the prospective parents. The
decision is sufficiently complex, however, that many couples find it bewildering.
Decision analysis provides a systematic means of both communicating the issues to
the parents and obtaining measures of the relative costs or burdens ofthe outcomes
from them.
The physician must advise the prospective parents of the likelihood of each
possible outcome: the birth of an unaffected child, the birth of an affected child, a
spontaneous abortion, and a therapeutic abortion. The prospective parents can
provide measures of the relative burden ofeach ofthese outcomes by answering two
questions:
Given no further diagnostic information, at what chance of a pregnancy's
resulting in an affected child would you choose to have a therapeutic abortion?
Given no further diagnostic information, at what chance of a pregnancy's
resulting in an affected child would you prefer that the pregnancy end by
spontaneous abortion?
If the birth of an affected child is the worst outcome and the birth ofan unaffected
child is the best, answers to these questions provide the relative costs or burdens of
therapeutic abortion, spontaneous abortion, and the birth of an affected child.
The Threshold and Sensitivity Analysis
A specific set of attitudes concerning the possible outcomes determine a threshold
probability [23] of having an affected child. If the chance ofan affected child exceeds
that threshold, amniocentesis should be recommended; if the chance is below that
threshold, amniocentesis should be discouraged. Another threshold exists for situa-
tions in which the likelihood ofa child's being affected and the risk ofamniocentesis
are both high: if that threshold is exceeded then therapeutic abortion might be
undertaken without prenatal diagnosis. Those situations were not considered in this
analysis.
This threshold forms the basis for one kind of sensitivity analysis. Although the
probability of a couple's having an affected child may not be precisely known,
reasonable estimates of the range can often be made. If the entire range lies on one
side of the threshold, then the decision would be constant for any value within that
range. In such circumstances, the decision is said to be "insensitive" to changes in that
parameter. Ifthe range extends on both sides ofthe threshold, then the decision may
be "sensitive" to changes and some care must be taken to narrow the range.
Another type of sensitivity analysis can be performed upon the thresholds them-
selves by calculating several alternative thresholds, based on differentestimates ofthe
relative costs ofthe outcomes, the risk ofamniocentesis, and the quality of informa-
tion provided. The effect offalse positives and false negatives is greatest when the cost
of the procedure is low. Indeed, since the risk of the procedure is relatively low,
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variations in the false negative and false positive rates have major effects upon the
decision; physicians must not only themselves consider these error rates but must also
discuss them with prospective parents.
Trisomy 21 and Maternal Age
Case 1 dealt with the issue ofamniocentesis for detection of translocation Down's
syndrome. Since the incidence of non-disjunction Down's syndrome increases with
advancing maternal age [29], parents are often offered amniocentesis when maternal
age is over thirty-five. The threshold for amniocentesis should reflect that dependency
on maternal age, but the age at which the procedure is indicated should vary with
parental attitudes. Fig. 5 demonstrates a typical relation between the cost ofabortion
and maternal age. The curve is quite flat below age thirty since the incidence of
Down's syndrome is less affected by maternal age in that range. Even at that age some
couples might elect prenatal diagnosis if they consider either the burden ofa Down's
child to be high or the burden of an abortion to be low.
Consistency
The techniques presented in this paper allow the physician to suggest a rational
decision to individual couples by replacing the complex decision by a series ofsimpler
ones. Ifthe prospective parents do not follow the suggestions ofthis analysis, they are
not wrong; rather, their decision is inconsistent either with the choices they made
when assessing the costs ofthe possible outcomes or with the structure ofthe model
itself. Either those simpler decisions were incorrect, the model was inappropriate, or
the ultimate decision about prenatal diagnosis was illogical.
As was explained above (c.f., Assumptions of the Analysis), maternal pain and
complications, non-fatal fetal complications, and dollar costs were ignored. In
circumstances where these or other factors not explicitly considered in the model are
important, the model would have to be extended. For example, if facilities for
processing amniotic fluid continue to be expensive and of limited availability, then
resource constraints will limit the total number of amniocenteses which can be
performed. In such circumstances it would not be appropriate to allow the parents'
attitudes to be the only utilities considered; overall societal good should also be
considered explicitly.
Evaluation
This decision analytic model should allow prospective parents to make better
decisions concerning prenatal diagnosis, but, ofcourse, this hypothesis must be tested
in a clinical trial. A major obstacle inconducting such a trial lies in theestablishment
of criteria for the evaluation of decisions. Since different parents will assign quite
different costs to the possible outcomes, it will be difficult to make comparisons: a
decision that might be optimal for one set of parents might be inappropriate for
another set in similar circumstances.
A first step in the evaluation of this technique might be to examine the acceptance
of this technique by prospective parents and to document their retention about the
possible outcomes of a pregnancy. Prior studies [27,28,36] have established the range
ofresults that can be expected through classical "non-directive" counseling and might
form a basis for comparison. In our experience with the clinical application of this
technique, most prospective parents easily understood the questions by which we
assessed their utilities toward the potential outcomes oftheir pregnancy and seemed
pleased with the explicit manner in which their attitudes were incorporated into the
decision-making process.
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FIG. 5. The Effect of Maternal Age in Down's Syndrome. The threshold cost ofabortion is plotted against maternal
age. Thresholds were calculated from age-specific occurrence rates [29]. The curve is analagous to the curve in Fig. 3, with
the assumptions that r = 0.005, n = 0,p = 0, CTU = CTA, and Cs = 0.5 XCTA. In otherwords we assumed that the error rates
were very small and that the burden of spontaneous abortion was one halfthe burden oftherapeutic abortion. Although
the curves shown in Figs. 3 and 4 (threshold cost as a function ofthe probability ofa child's being affected) are convex
upwards, the curve in this figure is concave upwards because the abscissa in this figure is maternal age, not probability.
The relation between maternal age and the probability ofa child's being affected by Down's syndrome rises quite sharply
as age increases, and this sharp rise governs, in large part, the shape of the curve in this figure.
Decision Analysis and Informed Consent
Social pressures and recent court decisions [37] have underscored the need that
patients understand all the issues involved in selecting diagnostic and therapeutic
procedures. This necessity is nowhere more important than in circumstances such as
prenatal diagnosis in which medical guidelines are not clearly established and deci-
sions are governed by subjective, ethical issues. Unfortunately, simply providing the
medical facts may not be sufficient to form a basis for informed consent [38]. Several
studies have shown a low rate of information retention after genetic counseling
[27,36]. Hence, the physician must insure that the parents understand the issues
involved. Avoiding the problem by not discussing amniocentesis would do an
injustice to the prospective parents and might make the physician legally liable if a
child affected by a "preventable" malformation were born [37].
The techniques presented in this paper can be used to help achieve informed
consent. The use ofexplicit diagrams (e.g., Fig. 1) can increase the parents' apprecia-
tion of their options. By obtaining the parents' assessment of the relative cost ofthe
various outcomes and by incorporating these values into the decision-making pro-
cess, the physician can make the parents equal partners in the decision. Such a
partnership is, however, not without additional difficulties for both the parents and
the physician. The parents must provide answers to several difficult, soul-searching
questions; the physician must both communicate the issues to the parents and
incorporate their attitudes into the decision-making process. These difficulties consti-
tute part of the burden of informed consent.
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